Hyperlipoproteinemia in patients with primary and secondary glomerular nephropathies
Razboĭnikov, S.; Shipkova, P.; Tishkov, I.; Shipkov, I.; Gruev, I.
Terapevticheskii Arkhiv 47(4): 50-55
1975
ISSN/ISBN: 0040-3660 PMID: 1145481 Document Number: 93265
Document emailed within 1 workday
Related Documents
Contri, D.; Wolf, D. 1977: Pathogenetic aspects of glomerular nephropathies caused by immune complexes and anti-glomerular basement membrane antibodies Pathologica 69: 997-998Müller-Wiefel, D.E.; Waldherr, R. 1992: Congenital glomerular nephropathies Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 140(2): 84-90
Díez, J.; Villaro, J.; Monfá, J.M.; Sánchez Ibarrola, A.; Purroy, A. 1981: Urinary abnormalities in various glomerular nephropathies Revista de Medicina de la Universidad de Navarra 25(4): 33-38
Schneer, J.H.; Chipail, A.; Constantinescu, V.; Brumăr, O.M. 1973: Anticoagulant treatment in glomerular nephropathies in children Pediatria 22(1): 69-73
Lagrue, G.; Branellec, A.; Intrator, L.; Moisy, M.; Sobel, A. 1979: Measurements of serum C3d in primitive chronic glomerular nephropathies La Nouvelle Presse Medicale 8(14): 1153-1156
Mahieu, P. 1985: Inflammatory reactions in glomerular nephropathies of immunologic origin Revue Medicale de Liege 40(24): 838-843
Haacke, H.; Parwaresch, M.R.; Mäder, C. 1976: The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 829-832
Jäger, E.; Sinzinger, H.; Widhalm, K.; Kaliman, J.; Höfer, R. 1982: Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis Wiener Klinische Wochenschrift 94(16): 421-425
Andĕl, M.; Brodan, V.; Kucerová, L.; Grafnetter, D.; Kuhn, E.; Veselková, A. 1980: Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term I.v. glucagon administration Casopis Lekaru Ceskych 119(22): 616-621
Coppola, R.; Guerra, L.; Ruggeri, Z.M.; Tarantino, A.; Mannucci, P.M.; Ponticelli, C. 1981: Factor VIII/von Willebrand factor in glomerular nephropathies Clinical Nephrology 16(5): 217-222
Tanaka, T.; Hashimoto, H.; Ohba, H.; Abe, M.; Yagi, S. 1986: The renin-angiotensin-aldosterone system in patients with chronic primary glomerular diseases Nihon Jinzo Gakkai Shi 28(9): 1261-1266
Ossi, E.; Mioni, G.; D'Angelo, A.; Bertaglia, E.; Huber, W.; Marcon, G.; Maschio, G.; Campanacci, L. 1970: On several cases of renal tubular acidosis secondary to interstitial or malformation nephropathies. Effects of treatment with NaHCO- 3 Giornale di Clinica Medica 51(10): 785-797
Józsa, L.; Kazár, G.; Fekete, G.; Magyari, Z.; Szepesi, A. 1979: The importance of primary operation from the point of view of mortality in patients with femoral neck fractures. II. Distribution of death causes after primary and secondary nailing Magyar Traumatologia Orthopaedia Es Helyreallito Sebeszet 22(1): 1-6
Varshavskiĭ, V.A.; Golitsina, E.P.; Rybin, P.N.; Fedorov, D.N. 2004: The role of viral infection in emergence and progression of primary glomerulonephritis and some nephropathies Arkhiv Patologii 66(6): 28-33
Ciświcka-Sznajderman, M. 1976: Pharmacological treatment of primary hyperlipoproteinemia Polski Tygodnik Lekarski 31(7): 289-291
Reuter, W.; Herrmann, W.; Starke, I.; Ries, W. 1976: Primary hyperlipoproteinemia and cardiovascular diseases in relation to age Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(23): 991-994
Laterza, G.; Clemenzia, G.; Russo, G.; Scibinetti, F.; Gentile, V. 1984: Enzymuria in chronic nephropathies. Diagnosis by the urinary enzyme method in chronic nephropathies Minerva Medica 75(27): 1617-1622
Mincou, I.; Străchinariu, R.; Georgesco, M. 1979: Specific treatment of primary hyperlipoproteinemia in diabetes mellitus Medecine Interne 17(2): 163-168
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Manojlović, D.; Lepsanović, L.; Micić, D.; Sumarac, M.; Kendereski, L.; Popović, V.; Mićić, J. 1991: Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia Srpski Arhiv Za Celokupno Lekarstvo 119(1-2): 22-25